Navigation Links
Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
Date:10/1/2007

mbination of the calcium channel blocker (CCB) amlodipine and the angiotensin receptor blocker (ARB) olmesartan medoxomil, or BENICAR(R). In the next several months, the company expects to launch a type 2 diabetes indication for its lipid-lowering drug, WelChol(R) (colesevalam hydrochloride). With FDA approval, WelChol will be the first LDL-lowering medication also indicated for improving glycemic control. And within two years, Daiichi Sankyo and its co-promotion partner Eli Lilly and Company hope to bring the anti-platelet agent prasugrel to market for patients with acute coronary syndrome.

Globally, Daiichi Sankyo currently ranks as one of the top twenty pharmaceutical companies, with sales last year exceeding $8 billion. As a company in existence for more than 100 years, Daiichi Sankyo is very well known in Japan-it is the country's second largest drug maker, ranking ahead of Astellas Pharma Inc. and Eisai Inc. whose sales are $7.5 and $4.6 billion, respectively.

"The legacy of Daiichi and Sankyo is more than a century of pharmaceutical experience in bringing important medical discoveries to market," Pieroni said. "We are continuing this tradition of solid R&D innovation and are confident that our company is well positioned as an emerging leader in cardiovascular care to excel in the challenging U.S. pharmaceutical marketplace-and in bringing more life sciences jobs to New Jersey."

Daiichi Sankyo Co., Ltd., (TSE: 4568), the U.S. organization's parent company, is traded on the Tokyo Stock Exchange.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., (pronounced DIE - EECH -EE SANK- EE - O) headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the wor
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Heart grows new cells
2. Body Grows Older As Cells Age
3. Emergency Department Strain As Ice Problems Grows
4. Indian Researcher Finds Human Urine Grows Better Fish Food
5. Depression has a worthwhile treatment
6. Reducing The Frequency Of Angina Attacks While Exercising
7. Some See A Hopeless End, While Others See An Endless Hope
8. Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs
9. Driving While Using A Mobile Phone May Be Dangerous
10. Care for the elderly at home while away during the festive season
11. Children Face Risk While Swimming
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 San ... and the international children’s medical charity, Operation Smile, ... new global partnership. , Campaign Details: RxOrganics is ... Rxmedical line to Operation Smile throughout 2015. RxOrganics ... on such sales so that every order placed online ...
(Date:4/1/2015)... TCS Healthcare Technologies (TCS), a leading ... management and population health arenas, is pleased to announce ... which is fully integrated with the ACUITY platform. , ... p.m. ET, will be led by Jeff Frater, RN, ... explore the feature-rich portal as well as the importance ...
(Date:4/1/2015)... 2015 Nike Golf Camps has expanded ... Arizona and Florida. These programs are specifically designed for ... in a golf-intensive environment and to learn about the ... of Arizona coaching legend, Rick LaRose, spends significant time ... gaps as it pertains to the recruiting and college ...
(Date:4/1/2015)... Oak Brook, IL (PRWEB) April 01, 2015 ... unfortunately benefited greatly from climate change in recent years, ... will develop an allergic reaction if exposed to poison ... as outdoor enthusiasts and families prepare for summer adventures ... of an uncomfortable poison plant reaction is greater than ...
(Date:3/31/2015)... 31, 2015 Due to its ... hire more caregivers, staffing personnel, and marketing managers, ... managers within the Greater Los Angeles area. In ... 1Heart Caregiver University has firmed up its training ... to provide quality in-home care through a client-centered ...
Breaking Medicine News(10 mins):Health News:RxOrganics Forges Unique Partnership to Bring More Smiles to Underserved Global Heath Communities 2Health News:TCS Healthcare Technologies Releases Acuity Connect 2Health News:TCS Healthcare Technologies Releases Acuity Connect 3Health News:US Sports Camps and Nike Golf Camps to Host Golf Development Camps in Arizona and Florida 2Health News:US Sports Camps and Nike Golf Camps to Host Golf Development Camps in Arizona and Florida 3Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3
... veterans face some unique health issuesMINNEAPOLIS/ST. PAUL, Minn., May ... to school this fall as a result of the ... ensure student veterans, unique needs are met, according to ... the University of Minnesota and Minnesota State ...
... Angeles, London, New Delhi, Singapore and Washington DC (May 29, 2009) ... an over-the-counter, rapid HIV test for home use, according to a ... MDM ) which is published by SAGE. , As ... are at greater risk for HIV infection will not be able ...
... DALLAS, May 29 BeaconEquity.com announces availability of alerts on ... trading. The alerts include recent news, trading activity and technical ... stock alerts for free by visiting ... Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI ), Peregrine Pharmaceuticals ...
... disease, risks may outweigh benefits, research suggests , , ... attack risk in people with no previous history of ... say British researchers who analyzed the results of 22 ... this group of patients is uncertain because the benefits ...
... & Lomb,s Expanding Ocular Pharmaceuticals Portfolio and Offers New ... Pathogens(1) - , MADISON, N.J., May 29 Bausch ... announced that the U.S. Food and Drug Administration (FDA) ... the treatment of bacterial conjunctivitis, commonly referred to as ...
... at Digestive Disease Week, addressing the topic of invention of new ... ... May 29, 2009 -- Zeus, Inc., a leader in polymer extrusions ... Digestive Disease Week in Chicago on June 1, 2009. Zeus ...
Cached Medicine News:Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 3Health News:FDA ignores critical information on home HIV tests 2Health News:Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants 2Health News:Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants 3Health News:Value of Taking Aspirin to Cut Heart Risk Varies 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 3Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 4Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 5Health News:Zeus to Present at Digestive Disease Week in Chicago 2
(Date:3/31/2015)... , March 31, 2015  SCILEX Pharmaceuticals, Inc., ... products focused on the treatment of pain, today announced ... Japan ), a member of ITOCHU Corporation ( ... the three leading sogo shosha (general trading companies) in ... investment in SCILEX.  ICF has worked closely with SCILEX ...
(Date:3/31/2015)... , March 31, 2015  SynCardia Systems, Inc. has ... (IDE) clinical study on the effective use of its ... The FDA approval will ... as 30 heart failure patients. Patients enrolled in this ... as a bridge to a donor heart transplant. ...
(Date:3/31/2015)... /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), ... marijuana products and a licensed producer ("LP") to cultivate ... Canada ) ("MMPR"), is pleased to announce ... the District of Saanich confirming ... now allows for commercial distribution of medical marijuana under ...
Breaking Medicine Technology:SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
... YORK, Aug. 30, 2011 Reportlinker.com announces that ... in its catalogue: Pharmaceutical ... http://www.reportlinker.com/p0605695/Pharmaceutical-Manufacturers---Global.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory This register contains ... the world. The register includes the following ...
... Ky., Aug. 29, 2011 Laboratory Supply Company (LABSCO), ... clinical laboratory products to hospitals, physician office laboratories, reference ... States, continues to expand its executive leadership team with ... and chief financial officer. Willett,s career has ...
Cached Medicine Technology:LABSCO Hires George Willett as New Vice President and Chief Financial Officer 2
Thermal Seal, Clear, Bulk...
Acetate Plate Sealers 100/Box...
... seals provide an adhesive-based sealing option for ... adhesive layer ensures secure sample storage or ... sealing during thermal cycling when supplemental pressure ... perforated end-tabs can be removed when using ...
TD silicone foam compression pad. Use with plates sealed with TDX or OptiTape....
Medicine Products: